Literature DB >> 6134091

Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease.

G J Alexander, K T Nouri-Aria, A L Eddleston, R Williams.   

Abstract

75 patients with various chronic liver diseases were investigated by simultaneous assay of suppressor-cell function and enumeration of suppressor T cells by monoclonal antibody. In chronic active hepatitis and primary biliary cirrhosis, substantial defects in suppressor-cell function were associated with negligible alterations in the proportions of suppressor cells. Defective suppressor-cell function was also evident in most patients with HBsAg-positive liver disease and in some with alcoholic liver disease. While the expected relations between suppressor-cell function and the proportions of helper or suppressor cells and the helper/suppressor ratio were apparent in alcoholic liver disease, the results in the HBsAg-positive, HBeAg-positive patients were in direct contrast. This apparent anomaly may reflect functional heterogeneity of the lymphocyte population detected by the monoclonal antibody OKT8, which identifies suppressor and cytotoxic cells. This study demonstrates that in the absence of simultaneous measurement of function, enumeration of T-cell subsets with monoclonal antibodies is an inadequate assessment of immunoregulatory balance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134091     DOI: 10.1016/s0140-6736(83)92410-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction?

Authors:  K T Nouri Aria; M Lombard; R Williams
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; G Mieli-Vergani; G Kenna; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  The relationship between T cell subsets and T suppressor cell function in hepatitis B.

Authors:  F Liu; P H Song; L J Hao
Journal:  J Tongji Med Univ       Date:  1987

4.  Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Authors:  G J Alexander; M Mondelli; N V Naumov; K T Nouriaria; D Vergani; D Lowe; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

5.  Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora.

Authors:  G A Filice; P S Hayes; G W Counts; J M Griffiss; D W Fraser
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

7.  Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

Authors:  J Devière; C Denys; L Schandene; F Romasco; M Adler; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

9.  Association between hepatitis B virus and pancreatic cancer.

Authors:  Manal M Hassan; Donghui Li; Adel S El-Deeb; Robert A Wolff; Melissa L Bondy; Marta Davila; James L Abbruzzese
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

10.  Loss of suppressor T-cells in active inflammatory bowel disease.

Authors:  N J Godin; D B Sachar; R Winchester; C Simon; H D Janowitz
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.